Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

60 years in oncology

EMCC 2011

23 - 27 Sep 2011

Published: 6 Oct 2011

Views: 6505

Rating:

Save

Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy

Prof Gordon McVie, Managing Editor of ecancer, talks to Prof Umberto Veronesi, Founder of the European Institute of Oncology about his ECCO award, starting up ecancer, and 60 years in oncology. Interviewed at the European Multidisciplinary Cancer Congress in Stockholm 23-27th September 2011.

Related Videos

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy ( Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

$The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )$

Precision oncology: Present and future in breast cancer

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Precision oncology: Present and future in breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Advancing breast cancer diagnosis in the developing world

Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury

Advancing breast cancer diagnosis in the developing world ( Dr Hans Junkermann, Prof Dr Erkin Arıbal and Dr Richard Rainsbury )

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival

Dr Jayant Vaidya - University College London, London, UK

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival ( Dr Jayant Vaidya - University College London, London, UK )

Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

IORT at Institute Paoli-Calmettes in France

Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France

IORT at Institute Paoli-Calmettes in France ( Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France )

IORT at the WITS University in South Africa

Prof Carol Benn - WITS University, Johannesburg, South Africa

IORT at the WITS University in South Africa ( Prof Carol Benn - WITS University, Johannesburg, South Africa )

More from ecancer